Biogen is a leading biotech company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
Thank you, @biogen, for once again hosting this year's Nano-rare Patient Colloquium!
100+ registrations in under 24 hrs! 🚨
The excitement for the 2026 NRPC is already building. Join us Oct. 7-8 for two days of powerful conversations, community, and collaboration focused on nano-rare disease.
Register now: https://t.co/6aTMTAzgmu
Today we recognize the individuals, families, researchers, and advocates working to raise awareness and advance research for the KIF1A community.
#KIF1A#RareDiseaseAwareness#RareDisease
TOMORROW! Join us for a joint webinar with @idtdna Principal Scientist Kim Lennox, MSc, and n-Lorem’s Assistant Director of ASO Strategy Research, Anthony Vu, PhD, as they explore antisense oligonucleotides (ASOs).
How to join:
Register here: https://t.co/sn5VTsIw26
Grateful for partners who show up in every way. 🧡
Thank you to Charles River for hosting a special visit with one of our patient families and a meaningful panel discussion with the Kosla family, n-Lorem, and your team. Your continued support helps make this work possible.
Join us for a joint webinar with IDT’s Principal Scientist Kim Lennox, MSc, and n-Lorem’s Assistant Director of ASO Strategy Research, Anthony Vu, PhD who explore ASOs in personalized medicine.
Register here: https://t.co/sn5VTsIw26
The vaccine dosage was obviously too high and done too many times.
I had the original Wuhan virus before there was any vaccine and it was much like any other cold/flu. Bad, but not terrible.
But my second vaccine shot almost sent me to the hospital. Felt like I was dying.
Part two of our series that pulls back the curtain on the scientific breakthroughs that make n-Lorem possible is out now. We call them miracles and without them, n-Lorem would not exist today.
Today’s miracle: Induced Pluripotent Stem Cells
Stream here: https://t.co/ET160KHb7Q
Defying Rare Disease premieres tonight on CNBC at 7 PM ET which follows families navigating rare diseases alongside the scientists, advocates, and innovators working that features familiar faces, including KIF1A patient Susannah and n-Lorem founder Dr. Stan Crooke!
It’s #RareDiseaseDay and the path forward is brighter when we walk it together.
Patient families, physicians, our team, friends, and loved ones came together to Chalk the Path Forward, filling our office sidewalk with messages of hope and awareness.
https://t.co/sFPLVRCb1B
@grok@lm1982tx@libsoftiktok But what if “social communication deficits + restricted/repetitive behaviors” are actually part of the newly discovered genetic disorders phenotype?
@grok@lm1982tx@libsoftiktok Thank you - if some cases of autism turn out to be genetic/inherited conditions newly discovered do they lose their autism diagnosis and do the numbers/prevalence get updated?